Correction: Detecting the percent of peripheral blood mononuclear cells displaying p-STAT-3 in malignant glioma patients
Article in Journal of Translational Medicine (March 2024)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
A first-in-human Phase I trial of the oral p-STAT3 inhibitor WP1066 in patients with recurrent malignant glioma
Article in CNS Oncology (May 2022)
Small-molecule targeting of signal transducer and activator of transcription (STAT) 3 to treat non-small cell lung cancer
Article in Lung Cancer (September 2015)